A Fresh Pair of Eyes
March 11, 2015
Global healthcare company GlaxoSmithKline (GSK) has pledged to be carbon neutral by 2050.
1 min read
March 11, 2015
Global healthcare company GlaxoSmithKline (GSK) has pledged to be carbon neutral by 2050.
1 min read
March 11, 2015
At Genentech, a member of the Roche Group, the Green BioPharma program aims to bring sustainability into R&D labs.
1 min read
March 11, 2015
Green thinking sometimes seems a long way off for those of us in medicinal chemistry.
1 min read
March 11, 2015
The field of green chemistry is concerned with minimization of waste and avoidance of toxic and hazardous substances in pharmaceutical products.
1 min read
March 11, 2015
A multimillion Euro project is pushing green chemistry forward in Europe. The secret of its success? Collaboration, collaboration, collaboration! CHEM21 is a €26 ($29) million project that brings together European pharmaceutical companies, universities and small to medium enterprises to develop more sustainable pharmaceutical manufacturing.
1 min read
March 11, 2015
Pushing for cleaner, greener manufacturing is not only good for the planet, it’s great for business. But it’s not a task that can be accomplished by one company or organization alone – only by learning from each other will we achieve a more sustainable future.
1 min read
March 10, 2015
With regulators looking for more differentiation between tablets, we must be bolder with solid dosage designs. There’s a whole world of color and shape out there – let’s give our vanilla world a makeover.
1 min read
March 10, 2015
With only one approved drug and many failures, the cancer vaccine field has lost some of its shine. Could nanotechnology brighten its prospects?
1 min read
March 10, 2015
Our ‘dynamic flowsheet model’ links API purification and processing with downstream tablet manufacturing to provide better control of the process variables and, ultimately, the critical quality attributes of the final pharmaceutical product. Here’s how.
1 min read
March 10, 2015
Sitting Down With… James Christie, Project Director for Manufacturing, Association of the British Pharmaceutical Industry (ABPI), London, UK.
1 min read
March 10, 2015
Cutting corners in process development will come back to haunt you – especially in the biopharmaceutical arena.
1 min read
March 10, 2015
Women’s health used to be considered solely in terms of maternal and reproductive health. Not anymore. As our knowledge of the basic biological differences between the sexes grows, it’s clear we must take action to ensure women are represented throughout the drug development process.
1 min read
March 10, 2015
Can nanotechnology pick up where personalized medicine leaves off?
1 min read
March 10, 2015
A ‘robot scientist’, capable of independently carrying out drug screening research, has been developed by UK researchers.
1 min read
March 10, 2015
Pharma companies look to new genetic screening technology to enhance drug discovery
1 min read
March 10, 2015
Only you have the answer. Nominate now.
1 min read
March 10, 2015
The FDA is not impressed with data mishaps or missing petri dishes – however unintentional...
1 min read
March 10, 2015
Research into rare diseases is on the rise, but are prices sustainable?
1 min read
March 9, 2015
Scientists in California have ‘unboiled’ an egg – with some interesting implications for biopharma...
1 min read
March 9, 2015
Can pharma get over its IP anxiety and embrace meaningful partnerships?
1 min read
False
False